My Expertise
Neuroscience & Clinical Neurology
Fields of Research (FoR)
Neurology and Neuromuscular DiseasesSEO tags
Biography
Professor Matthew Kiernan is the Chief Executive Officer and Institute Director at Neuroscience Research Australia. He holds appointments as Scientia Professor of Neuroscience at UNSW and Senior Staff Specialist in Neurology at South Eastern Sydney Local Health District, based at Prince of Wales Hospital. He is Chair of the World Federation of Neurology Specialty Group in Neurodegenerative Disease, Chair of the World Congress of Neurology,...view more
Professor Matthew Kiernan is the Chief Executive Officer and Institute Director at Neuroscience Research Australia. He holds appointments as Scientia Professor of Neuroscience at UNSW and Senior Staff Specialist in Neurology at South Eastern Sydney Local Health District, based at Prince of Wales Hospital. He is Chair of the World Federation of Neurology Specialty Group in Neurodegenerative Disease, Chair of the World Congress of Neurology, President of the Brain Foundation and Editor Emeritus of the Journal of Neurology, Neurosurgery & Psychiatry (BMJ Publishers UK), having served as Editor-in-Chief from 2010-2022.
My Grants
2022-2025 | FightMND Clinical Trial Grant: A Multi-arm, Adaptive, Group-sequential trial NETwork to evaluate drug efficacy in patients (MAGNET); Kiernan MC; $1.2M.
2019-2024 | NHMRC Medical Research Futures Fund MRFF: ALS Trials Australia (ALSTA) - to develop precision medicine; Kiernan MC, Vucic S, Wray N, Talman P, Needham M, Schulz D, Barnett M, Park S; $1.7M.
2019-2023 | NHMRC Practitioner Fellowship: Developing new therapies for neurodegeneration and dementia; Kiernan MC; National Health and Medical Research Council; $585,270.
2019-2023 | NHMRC Partnership Grant: Patient centred care for a progressive neurological disease-evidence driving policy; Kiernan MC, Wray N, Talman P, Vucic S, Mathers S, Henderson R, Bellgard M, Aoun S, Savulescu J, Rowe D; $1.6M
2018-2022 | NHMRC Program Grant: Frontotemporal Dementia and motor neurone degenerative syndromes; #APP1132524; $17,079,580.
My Qualifications
MBBS (Hons) (USYD), PhD (UNSW), DSc (UNSW), FRACP, FAHMS
My Awards
2022 | American Academy of Neurology Sheila Essey Award 'to acknowledge and honor an individual who is making significant contributions in research. The award recognizes seminal research breakthroughs in the search for the cause, prevention of and cure for ALS'.
2022 | Ramaciotti Medal for Excellence in Biomedical Research (Perpetual Trustees).
2021 | Royal Prince Alfred Foundation Research Medal.
2019 | Member (AM), General Division of the Order of Australia 'For significant service to medicine, and to medical education, in the field of neurology'.
My Research Activities
Clinical neurophysiology | peripheral nerve excitability and cortical nerve excitability
Frontotemporal Dementia and Motor Neurone Syndomes
Site of onset
Biomarkers
Mechanism of disease
Progression and spread of disease
Novel treatment strategies including regenerative medicine
Location
Margarete Ainsworth Building
Barker Street
Randwick NSW 2031